Saudi Arabia to begin Phase III trials for COVID-19 vaccine

0
3

DUBAI: Saudi Arabia will soon begin Phase III clinical trials on around 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics, a Saudi health ministry spokesman said on Sunday. Last month, CanSino’s co-founder said the company was in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of the vaccine candidate, Ad5-nCOV.

NO COMMENTS